Conference Coverage: European Hematology Association 2021 Virtual Congress
FDA to Reassess 6 Oncology Immunotherapy Indications Granted Accelerated Approval
The FDA will reassess 6 indications for immune checkpoint inhibitors that were granted accelerated approval but failed to prove clinical benefit in confirmatory trials.
For Staying Power, Diabetes Interventions May Need a Hands-on Element
